Issue 5/2020
Content (20 Articles)
Is biological therapy in systemic sclerosis the answer?
Durga Prasanna Misra, Sakir Ahmed, Vikas Agarwal
Macrophage activation syndrome in juvenile dermatomyositis: a systematic review
Dimitri Poddighe, Kaisar Dauyey
Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease—a randomised controlled trial
Nupoor Acharya, Shefali Khanna Sharma, Debashish Mishra, Sahajal Dhooria, Varun Dhir, Sanjay Jain
In-hospital mortality in patients with systemic lupus erythematosus: a study from Jordan 2002–2017
Marwan H. Adwan, Ula Qasem, Khader N. Mustafa
Rituximab effect in severe progressive connective tissue disease-related lung disease: preliminary data
Alejandro Robles-Perez, Jordi Dorca, Ivan Castellví, Joan Miquel Nolla, Maria Molina-Molina, Javier Narváez
High interleukin-18 and low FOXP3 mRNAs in peripheral blood of women with severe systemic lupus erythematosus: a cross-sectional study
Lyuba D. Miteva, Irena M. Manolova, Mariana G. Ivanova, Rumen M. Stoilov, Spaska A. Stanilova
Applicability of shear wave elastography for the evaluation of skin strain in systemic sclerosis
Piotr Sobolewski, Maria Maślińska, Jakub Zakrzewski, Łukasz Paluch, Elżbieta Szymańska, Irena Walecka
Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies
Michaela Koehm, Matthew J. McIntosh, Michael W. Hofmann, Varghese Abraham, Cem Gabay, Ernest H. Choy, Arthur Kavanaugh, Harald Burkhardt, Frank Behrens
The evaluation of anxiety, depression and quality of life scores of children and adolescents with familial Mediterranean fever
Arzu Önal Sönmez, Hafize Emine Sönmez, Mustafa Çakan, Mesut Yavuz, Gonca Keskindemirci, Nuray Aktay Ayaz
Methotrexate-related toxicity in patients with rheumatoid arthritis and renal dysfunction
Jung Sun Lee, Ji Seon Oh, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo, Seokchan Hong
Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years’ experience of a tertiary pediatric rheumatology center
Rahime Koç, Hafize Emine Sönmez, Mustafa Çakan, Şerife Gül Karadağ, Ayşe Tanatar, Figen Çakmak, Nuray Aktay Ayaz
Systemic lupus erythematosus and hydroxychloroquine-related acute intermittent porphyria
Enrique Esteve-Valverde, Alfonso Tapiz-Reula, Domingo Ruiz, Jaume Alijotas-Reig
Glomerulonephritis and Coombs-positive hemolytic anemia mimicking scleroderma renal crisis in an overlap of systemic lupus erythematosus and diffuse systemic sclerosis
Ali Taylan, Emel Tekin, Bahar Engin
Tocilizumab-induced anaphylaxis in patients with adult-onset Still’s disease and systemic juvenile idiopathic arthritis: a case-based review
Eun Hye Park, Eun Young Lee, Kichul Shin, Hyoun-Ah Kim
Pregnancy and Takayasu arteritis: case-based review
Nirvana Bharuthram, Mohammed Tikly
Acute pancreatitis and macrophage activation syndrome in pediatric systemic lupus erythematosus: case-based review
Qiang Lin, Man Zhang, Hanyun Tang, Yunyan Shen, Yun Zhu, Qinying Xu, Xiaozhong Li
Arthralgia as an initial presentation of COVID-19: observation
Beuy Joob, Viroj Wiwanitkit
Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs
Tsvetoslav Georgiev
COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence
Vincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone